Form 4: Protagenic Therapeutics, Inc.new Executive Buys Shares
Insider Transaction (Form 4)
Garo H Armen, EXEC. CHAIR & PRINCIPAL OFF and a Director of Protagenic Therapeutics, Inc.new, purchased 16,634 shares of common stock on August 20, 2026 for $0.59 per share.
Summary
- Open-market purchase: acquired 16,634 COMMON STOCK at $0.59 ($9,811) on August 20, 2026; holds 53,533 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $9,811, committing personal capital to the stock.
Insider Transactions
Garo H Armen — Director, Officer (EXEC. CHAIR & PRINCIPAL OFF)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Open-market purchase | COMMON STOCK | 16,634 | $1 | $9.8K | 53,533 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Open-market purchase (16,634 shares) |
Keywords
insider transaction, Form 4, PTIX, Protagenic Therapeutics, Inc.\new, bullish, Garo H Armen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.